Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02032017 |
Recruitment Status : Unknown
Verified January 2014 by Claudia Hendrickx, Universiteit Antwerpen.
Recruitment status was: Recruiting
First Posted : January 9, 2014
Last Update Posted : January 9, 2014
|
Sponsor:
Universiteit Antwerpen
Collaborator:
Stöpler Belgium nv
Information provided by (Responsible Party):
Claudia Hendrickx, Universiteit Antwerpen
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date ICMJE | January 7, 2014 | |||
First Posted Date ICMJE | January 9, 2014 | |||
Last Update Posted Date | January 9, 2014 | |||
Study Start Date ICMJE | October 2013 | |||
Estimated Primary Completion Date | December 2014 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures ICMJE |
change in time needed for the timed get up and go test [ Time Frame: baseline, 4 weeks, 12 weeks ] The subject is asked to stand up from a chair, walk 3m to a cone, return to the chair and sit down again. The time needed to perform this test is recorded in seconds.
|
|||
Original Primary Outcome Measures ICMJE | Same as current | |||
Change History | No Changes Posted | |||
Current Secondary Outcome Measures ICMJE |
|
|||
Original Secondary Outcome Measures ICMJE | Same as current | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title ICMJE | Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation. | |||
Official Title ICMJE | Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation Compared to the Anterolateral Approach. | |||
Brief Summary | The purpose of this study is to investigate whether revalidation following total hip replacement through the percutaneous approach is faster or better than following the anterolateral approach. We assume this would be the case since it is possible to spare a large part of the gluteus medius muscle with the percutaneous approach. | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Not Applicable | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Outcomes Assessor) Primary Purpose: Treatment |
|||
Condition ICMJE | Total Hip Arthroplasty | |||
Intervention ICMJE |
|
|||
Study Arms ICMJE |
|
|||
Publications * | Hendrickx C, De Hertogh W, Van Daele U, Mertens P, Stassijns G. Effect of percutaneous assisted approach on functional rehabilitation for total hip replacement compared to anterolateral approach: study protocol for a randomized controlled trial. Trials. 2014 Oct 8;15:392. doi: 10.1186/1745-6215-15-392. | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status ICMJE | Unknown status | |||
Estimated Enrollment ICMJE |
30 | |||
Original Estimated Enrollment ICMJE | Same as current | |||
Study Completion Date ICMJE | Not Provided | |||
Estimated Primary Completion Date | December 2014 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
|||
Sex/Gender ICMJE |
|
|||
Ages ICMJE | 50 Years to 80 Years (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | Belgium | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT02032017 | |||
Other Study ID Numbers ICMJE | B300201318915 | |||
Has Data Monitoring Committee | Yes | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Claudia Hendrickx, Universiteit Antwerpen | |||
Study Sponsor ICMJE | Universiteit Antwerpen | |||
Collaborators ICMJE | Stöpler Belgium nv | |||
Investigators ICMJE |
|
|||
PRS Account | Universiteit Antwerpen | |||
Verification Date | January 2014 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |